 |
|
|
|
|
|
|
|
|
| |
 |
|
|
|
|
|
|
| |
|
Updated: April 1, 2013
Please note that Guidelines marked with an asterisk (*) have been included in the Canadian Medical Association's Infobase: Clinical Practice Guidelines Database (CPGs) |
|
|
|
|
|
| |
|
|
|
| |
|
OAML Guidelines for Clinical Laboratory Practice
*CLP001:
|
Guidelines for the Use of Laboratory Tests for Assessment of Iron Overload
(Revised November, 2012)
|
*CLP002:
|
Guidelines for the Use of Serum Tests for Iron Deficiency
(Revised February, 2012)
|
CLP004:
|
Guidelines for the Ordering of Microscopic Urinalysis
(Revised June, 2012)
|
| CLP007: |
Guidelines for the Use of Serum Tests to Detect Renal Dysfunction
|
CLP011-
001: |
Guidelines for the Rejection of Specimens
(Revised March, 2007)
|
CLP011a
001: |
Pre-Analytical Laboratory Procedures for Medical Office Staff
(Revised March, 2007)
|
*CLP012:
*CLP012A: |
Guidelines for Testing for Viral Hepatitis
(Revised September, 2010)
Interpretation of Viral Hepatitis Laboratory Test Results
|
| CLP013: |
Guidelines for Ordering Urine Testing for Drugs-of-Abuse:Targeted and Screening Tests
(Revised March, 2013)
|
| *CLP014: |
Guideline for the Laboratory Monitoring of Oral Anticoagulation (Warfarin)
(Revised September, 2008)
|
|
A Patient's Guide to Anticoagulant Therapy
|
|
French Translation
Guide du patient sur l'anticoagulothérapie
|
| |
Management of Excessive Anticoagulation
|
| *CLP015: |
Guideline for the Use of Laboratory Tests to Detect Thyroid Dysfunction
(Revised July, 2007)
|
*CLP017: |
Guideline forAdult Lipid Testing
(Revised August, 2010)
Calculator*
* Some material in this table is copyright Canadian Medical Association. Refer to "Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update - Reproduced with permission, Can J Cardiol 2006;22(11):915-16
|
CLP018:
|
Guidelines for the Collection and Testing for Ova and Parasites in Symptomatic Patients
|
| CLP019: |
Guidelines for the Collection of Stool Specimens for Culture and Sensitivity
|
| *CLP021: |
Guidelines for Ordering Serum Levels of Gonadotropins (FSH, LH) and Prolactin
(Revised July, 2008)
|
| CLP022: |
Indications for Urine Culture
|
| CLP023: |
Guidelines for the Ordering of Erythrocyte Sedimentation Rate (ESR) |
| CLP024: |
Guidelines for Collection and Storage of Bacteriology Specimens for Testing
(April, 2004) |
| *CLP025: |
Guideline for Reporting Laboratory Test Results
(Revised September, 2009) |
| *CLP026: |
Guideline for the Appropriate Ordering of Serum Tests for 25-hydroxy Vitamin D and 1,25 dihydroxy Vitamin D
(June, 2010)
|
| *CLP026: |
Guideline for Folate Testing
(September, 2009) |
The following Guidelines have been replaced or withdrawn:
CLP003 (Replaced by Guideline CLP023)
CLP005, CLP006, CLP008, CLP009, CLP010, CLP016 (Replaced by Guideline CLP015, revised July 2007)
C020 Communiqué - Reporting Laboratory Test Results, (Replaced by CLP025, September, 2009)
|
|
|
|
|
OAML Communiqués for Practitioners
|
|
Warning & Disclaimer
These Guidelines have been developed to assist community laboratories and practitioners who order tests from community laboratories. Users must ensure that the practices comply with all specific legislative and/or accreditation requirements that apply to their practices or organizations.The Guidelines are not meant to supersede directives from government, practitioners' colleges or professional associations, and they are not meant to address every element of the topic or be construed as legal advice. Given the complexity of legal requirements, users are reminded that whenever there is uncertainty regarding whether some aspect of a Guideline is appropriate for their practice or organization further direction could be obtained from the Medical Director of the laboratory, their own professional association, college and or legal counsel or appropriate government ministry.
|
